Go Back

Company or ticker...

BioCryst Pharmaceuticals

BioCryst develops and sells medicines for rare diseases, including treatments that prevent attacks of hereditary angioedema.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

BCRX

2.0B

2.1

n/a

-1.92%

Key Facts

M. Cap

PS

PE

YTD

2.0B

2.1

n/a

-1.92%

10MA

20MA

50MA

200MA

$BCRX

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now